Resources|Articles|November 8, 2024
mAbs Scale-up video
Author(s)Avantor
Scaling up monoclonal antibody (mAb) production can be challenging, but it doesn't have to slow you down. Explore how our large-volume handling solutions, GMP-grade chemicals and customized solutions for process development, optimization, and validation help you scale up quickly and meet regulatory standards with confidence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Excipient Innovation and the Regulatory Tug-of-War: Navigating Threats to Availability and Safety
4
US and European Pharma Manufacturing Face Diverging Paths to Resilience
5
